Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Monthly Archives: May 2013
Stem Cell Patient Treated With Adult Stem Cell Therapy – Video
Posted: May 5, 2013 at 4:41 pm
Stem Cell Patient Treated With Adult Stem Cell Therapy
By: Shaun Scott
Continue reading here:
Stem Cell Patient Treated With Adult Stem Cell Therapy - Video
Posted in Cell Therapy
Comments Off on Stem Cell Patient Treated With Adult Stem Cell Therapy – Video
What Is Stem Cell Therapy? – Innovations Stem Cell Center – Video
Posted: May 5, 2013 at 4:41 pm
What Is Stem Cell Therapy? - Innovations Stem Cell Center
http://www.InnovationsStemCellCenter.com 214.699.6948.
By: InnovationsStemCell
The rest is here:
What Is Stem Cell Therapy? - Innovations Stem Cell Center - Video
Posted in Stem Cell Therapy
Comments Off on What Is Stem Cell Therapy? – Innovations Stem Cell Center – Video
Streak- Post Stem Cell Therapy Day 9 – Video
Posted: May 5, 2013 at 4:41 pm
Streak- Post Stem Cell Therapy Day 9
Looking good after moving sheep this morning, taking a morning walk through the woods, an evening walk to the river and generally running amuck with his cani...
By: Laura Hanley
Read the rest here:
Streak- Post Stem Cell Therapy Day 9 - Video
Posted in Cell Therapy
Comments Off on Streak- Post Stem Cell Therapy Day 9 – Video
hESC Research Totals $458 Million out of $1.8 Billion from California Stem Cell Agency
Posted: May 5, 2013 at 3:10 am
The California stem cell agency today
said that it has awarded $458 million to fund research involving
human embryonic stem cells (hESC) out of a total of $1.8 billion it
has given away during the past eight years.
The amount is of some interest because
the key reason that the agency now exists is the perceived
need in 2004 to fund hESC research in the wake of the Bush
Administration restrictions on federal funding in that area. The
restrictions created a national uproar in the scientific and patient
advocate community, which feared that promising therapies would never
be developed.
the key reason that the agency now exists is the perceived
need in 2004 to fund hESC research in the wake of the Bush
Administration restrictions on federal funding in that area. The
restrictions created a national uproar in the scientific and patient
advocate community, which feared that promising therapies would never
be developed.
The $35 million ballot campaign to
create the agency focused hard on hESC research to the virtual
exclusion of any mention of adult stem cell research. Opposing the
effort were such forces as the anti-abortion movement and the
Catholic church. But this month LifeNews.com carried a mildly
approving item that pointed to the agency's turn towards adult stem
cell research.
create the agency focused hard on hESC research to the virtual
exclusion of any mention of adult stem cell research. Opposing the
effort were such forces as the anti-abortion movement and the
Catholic church. But this month LifeNews.com carried a mildly
approving item that pointed to the agency's turn towards adult stem
cell research.
When the Obama administration lifted
the Bush restrictions, some questions were raised about the need for
the California effort, which is costing state taxpayers $6 billion,
including interest. But those concerns received little public
attention and quickly died out.
the Bush restrictions, some questions were raised about the need for
the California effort, which is costing state taxpayers $6 billion,
including interest. But those concerns received little public
attention and quickly died out.
Funding for the agency comes through
state bonds. Cash for new awards is scheduled to run out in 2017. The
agency is looking at developing a public-private effort for thefuture that would need a $50 to $200 million “public investment”
and major private funding.
state bonds. Cash for new awards is scheduled to run out in 2017. The
agency is looking at developing a public-private effort for thefuture that would need a $50 to $200 million “public investment”
and major private funding.
Amy Adams, CIRM's communications
manager, provided the $458 million figure following publication of
this item yesterday on the California Stem Cell Report.
manager, provided the $458 million figure following publication of
this item yesterday on the California Stem Cell Report.
Posted in Stem Cells, Stem Cell Therapy
Comments Off on hESC Research Totals $458 Million out of $1.8 Billion from California Stem Cell Agency
‘Praise’ for California Stem Cell Agency from Unlikely Corner
Posted: May 5, 2013 at 3:10 am
The California stem cell agency this
month received what some might consider a gesture of approval from a
longtime foe – LifeNews.com.
LifeNews is a site devoted to
anti-abortion efforts and information and is sharply opposed to research
involving human embryonic stem cells.
anti-abortion efforts and information and is sharply opposed to research
involving human embryonic stem cells.
So it was with some surprise that we
read a tacit endorsement of recent CIRM activities in an April 22 piece written by Gene Tame out of Sacramento. It said the most recent
$32 million grant round from CIRM “demonstrates – again – where
the future of stem cell reserch lies.”
read a tacit endorsement of recent CIRM activities in an April 22 piece written by Gene Tame out of Sacramento. It said the most recent
$32 million grant round from CIRM “demonstrates – again – where
the future of stem cell reserch lies.”
Tame wrote,
“CIRM has been steadily moving away
from its original mission to give preferential
treatment to funding for human embryonic stem cell research
(hESCR). Instead, after adopting a renewed
emphasis on translating research into clinical trials, CIRM
has more and more shifted the bulk of its grants towards funding
research utilizing adult stem cells and other alternatives to hESCR,
such as induced
pluripotent stem cells (iPSCs).”
Tame continued,
“(T)he lack, once again, of funding
for hESCR only serves to highlight how old and dated that approach to
finding treatments and cures increasingly seems.”
Tame is correct in his assertion that
the stem cell agency has moved a considerable distance from its
reason for being – research involving human embryonic stem cells.
In 2004, the ballot campaign to create the agency pitched voters hard
on hESC research and made no real mention of adult stem cells.
Instead, it focused on the threat from the Bush Administration with its
restrictions on hESC research, which have been lifted by the Obama
Administration. .
the stem cell agency has moved a considerable distance from its
reason for being – research involving human embryonic stem cells.
In 2004, the ballot campaign to create the agency pitched voters hard
on hESC research and made no real mention of adult stem cells.
Instead, it focused on the threat from the Bush Administration with its
restrictions on hESC research, which have been lifted by the Obama
Administration. .
In 2010, a study by a Georgia Tech
academic, Aaron Levine, reported that through 2009 only 18 percent of California's dollars went for grants that were "clearly" not eligible for federal funding under the Bush restrictions.
academic, Aaron Levine, reported that through 2009 only 18 percent of California's dollars went for grants that were "clearly" not eligible for federal funding under the Bush restrictions.
At the date of the study, CIRM had not
publicly disclosed statistics on its funding of hESC research.
publicly disclosed statistics on its funding of hESC research.
Today, however, its web site shows that only about 240 of the 595 awards that it has handed out are going for hESC research. CIRM has not made public the dollar value of
those 240 awards, but it has given away a total of $1.8 billion. (Following publication of this item, the agency told the California Stem Report that it has funded $458 million in hESC research.)
those 240 awards, but it has given away a total of $1.8 billion. (Following publication of this item, the agency told the California Stem Report that it has funded $458 million in hESC research.)
A footnote: Levine was a member of the
blue-ribbon Institute of Medicine panel that recommended sweeping
changes at CIRM.
blue-ribbon Institute of Medicine panel that recommended sweeping
changes at CIRM.
Posted in Stem Cells, Stem Cell Therapy
Comments Off on ‘Praise’ for California Stem Cell Agency from Unlikely Corner
Dr. Ernesto Gutierrez is Named President of World Stem Cells Clinic, a Stem Cell Research and Stem Cell Treatment …
Posted: May 4, 2013 at 11:48 am
Tampa, FL (PRWEB) May 04, 2013
World Stem Cells Clinic in Cancun is pleased to announce the appointment of Dr. Ernesto Gutierrez to the position of President of their medical lab and treatment center. Dr. Gutierrez brings experience and intensity to his new position at World Stem Cells Clinic and promises he and his team of experts will provide the best medical care available in the world to improve their patients quality of life.
Dr. Ernesto Gutierrez is an extensively educated physician. He is a graduate from the Universidad Anhuac Norte, School of Medicine in Mexico City and additionally holds a Post-Graduate Degree in Aesthetic and Anti-Aging Medicine from the Instituto Mexicano de Medicina Antienvejecimiento y Esttica, Guadalajara, Mexico. He holds active membership of both the Mexican College of Aesthetic and Anti-Aging Medicine and the Age Management Medicine Group. Dr. Gutierrez has spent considerable time in additional training in the US, with rotations in both Florida and Nevada for two specialty organizations and is certified in Age Management Medicine by the Cenegenics Education and Research Foundation part of Cenegenics Medical Institute in Las Vegas, Nevada. His bilingual English and Spanish skills, both in medical and conversational applications, are excellent. Dr. Gutierrez is the perfect addition to the team given his thorough understanding of both the North and South American medical systems.
Dr. Ernesto Gutierrez explains how the clinic and laboratory at World Stem Cells Clinic in Cancun were designed, built and are operated under the stringent guidelines as established by The International Cellular Medical Society (ICMS) and the US Food and Drug Administrations Good Tissue Practice (cGTP) regulations for pharmaceutical, biologics and clinical laboratories. The strict adherence to these established guidelines and policies guarantees the highest quality of clinical care and stem cell treatment safety for the patient. At World Stem Cells Clinic they continually strive to improve the patients outcomes with breakthrough research and by creating new cells and protocols.
Both the US patient management team at World Stem Cells, LLC (http://worldstemcells.com/) and their Cancun patient management team at World Stem Cells Clinic (http://worldstemcellsclinic.com/) offer medical information on the stem cell treatments provided by the doctors, help patients arrange transportation to Cancun and within the city, hotels, medical records procurement, and basically ensure that their every need is met.
Dr. Gutierrez says, "we will treat you like family!"
Working under the guidelines set forth by ICMS, World Stem Cells Clinic (http://worldstemcellsclinic.com/) provides Stem Cell Treatment for Ankylosing Spondylitis, Autism, Cerebral Palsy, Charcot-Marie-Tooth Disease (CMT), Crohns Diseases, COPD, Fuchs disease, Guillain-Barre Syndrome, Hashimotos Thryroiditis, ITP, Kidney Diseases, Macular Degeneration, Lupus (SLE), Multiple Sclerosis, PAD, Parkinsons disease, Rheumatoid Arthritis, Scleroderma, Stroke, Ulcerative Colitis at its contract Clinics, GLP laboratory, doctors and hospitals in the beautiful resort area of Cancun. They endeavor to provide the best care possible at a competitive price while providing documentation of all treatments that can be used to provide better future care and scientific data to the medical industry. World Stem Cells Clinic is participating in ICMS (International Cellular Medical Society) Stem Cell Reimplantation Registry. They provide Stem Cell Treatments to patients in need.
Go here to read the rest:
Dr. Ernesto Gutierrez is Named President of World Stem Cells Clinic, a Stem Cell Research and Stem Cell Treatment ...
Posted in Stem Cells
Comments Off on Dr. Ernesto Gutierrez is Named President of World Stem Cells Clinic, a Stem Cell Research and Stem Cell Treatment …
Windpipe grown from stem cells
Posted: May 4, 2013 at 11:48 am
Windpipe grown from stem cells
Lindsey Tanner (AP) / 4 May 2013
A2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.
Hannah Warren has been unable to breathe, eat, drink or swallow on her own since she was born in South Korea in 2010. Until the operation at a US hospital, she had spent her entire life in a hospital in Seoul. Doctors there told her parents there was no hope and they expected her to die.
The stem cells came from Hannahs bone marrow, extracted with a special needle inserted into her hip bone. They were seeded in a lab onto a plastic scaffold, where it took less than a week for them to multiply and create a new windpipe.
The windpipe was implanted on April 9 in a nine-hour procedure.
Early signs indicate the windpipe is working, Hannahs doctors announced, although she is still on a ventilator. They believe she will eventually be able to live at home and lead a normal life.
We feel like shes reborn, said Hannahs father, Darryl Warren.
They hope that she can do everything that a normal child can do but its going to take time. This is a brand new road that all of us are on, he said in a telephone interview. This is her only chance but shes got a fantastic one and an unbelievable one.
Warren choked up and his wife, Lee Young-mi, was teary-eyed at a hospital news conference. Hannah did not attend because she is still recovering from the surgery. She developed an infection after the operation but now is acting like a healthy 2-year-old, her doctors said.
Go here to read the rest:
Windpipe grown from stem cells
Posted in Stem Cells
Comments Off on Windpipe grown from stem cells
Girl, 2, makes medical history with stem cell surgery – Video
Posted: May 3, 2013 at 3:42 pm
Girl, 2, makes medical history with stem cell surgery
Born with no windpipe, Hannah Warren was kept alive for two and a half years by a tube inserted from her mouth into her lung, spending her life in an intensi...
By: NewsTheVideo
Original post:
Girl, 2, makes medical history with stem cell surgery - Video
Posted in Stem Cell Videos
Comments Off on Girl, 2, makes medical history with stem cell surgery – Video
Stem Cell Treatments for Spinal Cord Injury: Theo K. – Stem Cell Institute Panama – Video
Posted: May 3, 2013 at 3:42 pm
Stem Cell Treatments for Spinal Cord Injury: Theo K. - Stem Cell Institute Panama
Theo Kostoulas is a T-6 complete spinal cord injury patient. He received a course of 16 stem cell therapy injections using umbilical cord-derived stem cells ...
By: cellmedicine
Read the rest here:
Stem Cell Treatments for Spinal Cord Injury: Theo K. - Stem Cell Institute Panama - Video
Posted in Stem Cell Treatments
Comments Off on Stem Cell Treatments for Spinal Cord Injury: Theo K. – Stem Cell Institute Panama – Video
Research and Markets: Cell Therapy – Technologies, Markets and Companies – Updated 2013 with New Companies and Profiles
Posted: May 3, 2013 at 6:42 am
DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/2v6lkd/cell_therapy) has announced the addition of Jain PharmaBiotech's new report "Cell Therapy - Technologies, Markets and Companies" to their offering.
This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants. Role of cells in drug discovery is also described. Cell therapy is bound to become a part of medical practice.
Stem cells are discussed in detail in one chapter. Some light is thrown on the current controversy of embryonic sources of stem cells and comparison with adult sources. Other sources of stem cells such as the placenta, cord blood and fat removed by liposuction are also discussed. Stem cells can also be genetically modified prior to transplantation.
Cell therapy technologies overlap with those of gene therapy, cancer vaccines, drug delivery, tissue engineering and regenerative medicine. Pharmaceutical applications of stem cells including those in drug discovery are also described. Various types of cells used, methods of preparation and culture, encapsulation and genetic engineering of cells are discussed. Sources of cells, both human and animal (xenotransplantation) are discussed. Methods of delivery of cell therapy range from injections to surgical implantation using special devices.
Cell therapy has applications in a large number of disorders. The most important are diseases of the nervous system and cancer which are the topics for separate chapters. Other applications include cardiac disorders (myocardial infarction and heart failure), diabetes mellitus, diseases of bones and joints, genetic disorders, and wounds of the skin and soft tissues.
Regulatory and ethical issues involving cell therapy are important and are discussed. Current political debate on the use of stem cells from embryonic sources (hESCs) is also presented. Safety is an essential consideration of any new therapy and regulations for cell therapy are those for biological preparations.
The cell-based markets was analyzed for 2012, and projected to 2022. The markets are analyzed according to therapeutic categories, technologies and geographical areas. The largest expansion will be in diseases of the central nervous system, cancer and cardiovascular disorders. Skin and soft tissue repair as well as diabetes mellitus will be other major markets.
The number of companies involved in cell therapy has increased remarkably during the past few years. More than 500 companies have been identified to be involved in cell therapy and 287 of these are profiled in part II of the report along with tabulation of 273 alliances. Of these companies, 158 are involved in stem cells. Profiles of 72 academic institutions in the US involved in cell therapy are also included in part II along with their commercial collaborations. The text is supplemented with 55 Tables and 12 Figures. The bibliography contains 1,050 selected references, which are cited in the text.
Key Topics Covered:
Read more from the original source:
Research and Markets: Cell Therapy - Technologies, Markets and Companies - Updated 2013 with New Companies and Profiles
Posted in Cell Therapy
Comments Off on Research and Markets: Cell Therapy – Technologies, Markets and Companies – Updated 2013 with New Companies and Profiles
